The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen, Art Tempi, AstraZeneca, Clovis, Connect Medica, Eisai, Exact Sciences, Gedeon Richter, Gilead Science, GSK, Hexal, I-Med-Institute, Jörg Eickeler, Laborarztpraxis Walther et al., Lilly, MCI, Medscape, MSD, Medtronic, Novartis, Onkowissen, Pfizer, p; AstraZeneca, Biom’Up, Celgene, Clearcut, Neodynamics, Novartis, pfm medical, Roche, RTI Surgical
Consulting or Advisory Role - Agendia, Amgen, AstraZeneca, Aurikamed, Becton/Dickinson, Biom‘Up, ClearCut, Clovis, Daiichi Sankyo, Eisai, Exact Sciences, Gilead Science, Grünenthal, GSK, Lilly, MSD, Neodynamics, Novartis, Onkowissen, Organon, Pfizer, pfm Medical, Pierre-Fabre, Roche,
Research Funding - Endomag, Exact Sciences
Travel, Accommodations, Expenses - Amgen, Art Tempi, AstraZeneca, Clearcut, Clovis, Connect Medica, Daiichi Sankyo, Eisai, Exact Sciences, Gilead, Hexal, I-Med-Institute, Lilly, MCI, MSD, Neodynamics, Novartis, Pfizer, pfm Medical, Roche, RTI Surgical, Seagen; Amgen, AstraZeneca, Celgene, Daiichi Sanyko, Gilead, Hexal, Lilly, Neodynamics, Novartis, Pfizer, Pierre Fabre, Roche, Sirius Medical
Other Relationship - Amgen, ClearCut, Clovis, Organon, pfm medical, Roche, Servier

Radar reflectors for marking of target lymph nodes in patients receiving neoadjuvant chemotherapy for breast cancer: A subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.
 
Maggie Banys-Paluchowski
Consulting or Advisory Role - Amgen; AstraZeneca; Canon Medical System; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis/Pfizer; Onkowissen; pfm medical; Pierre Fabre; Roche; Samsung; Seagen; Sirius Medical
Speakers' Bureau - Amgen; AstraZeneca; Canon Medical System; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD; Novartis/Pfizer; Onkowissen; pfm medical; Pierre Fabre; Roche; Samsung; Seagen; Sirius Medical
Research Funding - Endomagnetics (Inst); Exact Sciences; Hologic; mammotome (Inst); Merit Medical Systems (Inst); Sirius Medical
Travel, Accommodations, Expenses - Lilly; Pfizer
 
Timo Basali
No Relationships to Disclose
 
Steffi Hartmann
No Relationships to Disclose
 
Jana de Boniface
No Relationships to Disclose
 
Oreste Davide Gentilini
No Relationships to Disclose
 
Elmar Stickeler
No Relationships to Disclose
 
Christine Mau
No Relationships to Disclose
 
Franziska Ruf
No Relationships to Disclose
 
Sarah Froehlich
No Relationships to Disclose
 
Maria Luisa Gasparri
No Relationships to Disclose
 
Marc Thill
No Relationships to Disclose
 
Florentia Peintinger
No Relationships to Disclose
 
Guldeniz Karadeniz Cakmak
No Relationships to Disclose
 
Isabel T. Rubio
Honoraria - SIRIUS MEDICAL
Consulting or Advisory Role - AstraZeneca
 
Dagmar Langanke
No Relationships to Disclose
 
Sonja Cardenas Ovalle
No Relationships to Disclose
 
Sabine Riemer
No Relationships to Disclose
 
Achim Rody
No Relationships to Disclose
 
Ellen Schlichting
No Relationships to Disclose
 
Thorsten Kuehn
No Relationships to Disclose